REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Combatting Pediatric Nonalcoholic Fatty Liver Disease

Pediatric Fatty Liver Disease
The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center has established a multi-disciplinary clinic for the treatment of pediatric nonalcoholic fatty liver disease.

This clinic in Sheba is the first of its kind in Israel, and its goal is to supply a comprehensive response to this growing problem among children.

The Cause of Fatty Liver

Children and adults with this disease are more prone to developing liver cirrhosis and other hepatic issues, and fatty liver is the most frequent reason for liver transplants in developed nations. This all ties in with the obesity epidemic in modernized countries.

Obesity is the most common cause of fatty liver in both children and adults, in addition to being responsible for other comorbid conditions like abnormal cholesterol levels, high blood pressure, and type 2 diabetes. Left untreated, fatty liver can lead to liver failure and the need for a liver transplant.

There are typically few apparent signs of the disease in its early stages and diagnosis is usually made by ultrasound. Only in later stages do elevated liver enzymes in the blood and jaundice appear.

Pediatric Fatty Liver Disease

A Holistic Response

Directed by Dr. Avishay Lahad, senior physician in the Pediatric Gastroenterology Unit, and Dr. Kineret Mazor-Aronovitch, senior physician in the Pediatric Endocrinology Unit, the Pediatric Fatty Liver Clinic at Safra Children’s Hospital will tackle this problem in a variety of ways. These include psychosocial support, diet and nutrition guidance, lifestyle changes, and medications. In continuing Sheba’s tradition of excellence in medical research, clinical trials will also be conducted at the clinic.

Related

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More